alexa Abstract | Synthesis of a combined prodrug of albendazole and metronidazole

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


The treatment of hydatidosis is primarily surgical but can cause morbidity or mortality, hence the int erest in many cases of medical treatment whose main representativ e is albendazole. The efficacy of this compound aga inst Echinococcus granulosus cysts is proved, but limite d by its poor bioavailability. Some prodrugs of alb endazole have been described but no bioavailability study has sho wn their interest to present. The new a combined pr odrug of albendazole and metronidazole was synthesized. The compound thus prepared was characterized by this ph ysical (TLC) and spectral data (ESI-MS).

To read the full article Peer-reviewed Article PDF image

Author(s): J El harti M Ansarand J Taoufik


Albendazole, Synthesis, Prodrug., prodrug, albendazole, metronidazole

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version